Literature DB >> 4125022

Remission of melanoma with D.N.C.B. treatment.

S Malek-Mansour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4125022     DOI： 10.1016/s0140-6736(73)92103-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.

Authors:  D K Johnson; J E Pontes; R Izbicki; J M Pierce
Journal:  Urol Res       Date:  1980

2.  [Long-term locally-recurrent melanoma].

Authors:  A G Bach; W C Marsch; C Richter; D Lübbe; P Helmbold
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

Review 3.  [Therapy of cutaneous metastases of malignant melanoma].

Authors:  P Rehberger; S Eppinger; A Stein; J Schmitt
Journal:  Hautarzt       Date:  2006-12       Impact factor: 0.751

Review 4.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

5.  Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.

Authors:  Elaine G Rodrigues; Andrey Ss Dobroff; Clarissa F Cavarsan; Thaysa Paschoalin; Leonardo Nimrichter; Renato A Mortara; Edson Lucas Santos; Marcos A Fázio; Antonio Miranda; Sirlei Daffre; Luiz R Travassos
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

6.  Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.

Authors:  P Terheyden; A-K Kortüm; H-J Schulze; B Durani; R Remling; C Mauch; V Junghans; D Schadendorf; U Beiteke; M Jünger; J C Becker; E-B Bröcker
Journal:  J Cancer Res Clin Oncol       Date:  2007-03-03       Impact factor: 4.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.